With $30 Million Gift, UAB Says Cancer Research is the Future of Birmingham
Eva Carter is in her 70s and for most of her life, she says she never had any health problems. That changed five years ago.
“I was bulldozed with, ‘You have the most aggressive type of breast cancer,’” Carter says.
She received a diagnosis of triple negative breast cancer. Her doctors at UAB recommended a clinical trial. She would test out a new drug therapy not yet approved by the FDA. Carter agreed to give it a try.
“I was fighting for my life and anything that I could do to enhance my chances of living longer, I was going to do it,” she says. “If it didn’t work, it didn’t work.”
Clinical trials are experiments, research studies to test the effectiveness of a new drug. The cancer center’s director, Dr. Michael Birrer, says that should not deter patients. He says today, more than ever, these studies are carefully done and represent the future of oncology research. For that reason, the center wants to do more of them, with plans to eventually triple its number of clinical trials. Birrer says they are especially interested in increasing the amount of early phase trials, when drugs are first tested on humans.
“It’s no longer, ‘Hey here’s a phase 1 and your chance of responding is very low,’” Birrer says. “We now have success rates in these trials that’s high, and so it’s much more relevant to patients.”
There is also an economic incentive. Birrer says the recent $30 million gift from O’Neal Industries will help fund physician-led research, hire clinical staff and increase patient participation. This lays the groundwork to attract small pharmaceutical, or biotech companies. Birrer says these groups are changing the face of research. They are nimble and hungry to develop new therapies. With enough investment, he says Birmingham could develop a biotech park in the future.
“Companies will come and say, ‘We have a new agent, looks good. Can you open this trial up and get the job done?’” Birrer says. “If we can do that fast enough and we do that often enough, I think they’ll open up an office down here or they might even bring their headquarters down here.”
For patients, that means access to the newest therapies, and they typically do not have to pay for treatment. But participating in a clinical trial is not easy. They often require daily or weekly visits to the cancer center and following a diet or exercise plan. Additionally, there are the side effects. For Eva Carter, it was worth it.
“My oncologist called me at 8’oclock one night, and I said, ‘Oh lord, does this mean I’m dead?’” Carter says, “and he called and said, ‘I just saw your MRI and we can’t even measure the tumor now. We can’t even measure it.’”
Carter says she understands why some people hesitate to participate in trials. Specifically within the African-American community, she says there is a legacy of distrust, marked by the Tuskegee study, when African-American men were unknowingly left untreated for syphilis for decades. Carter says that is why it is especially important patients have doctors they can trust, who explain the clinical trial and any risks associated with it. She also says patients should do their own research.
“I am so happy that the lord gave me the wisdom and the courage and the internet to look up the information on a clinical trial,” Carter says.
This year, more than 500 people have participated in a clinical trial at the O’Neal Comprehensive Cancer Center at UAB. Next year, the goal is to enroll about 700. The growth is expected to drive economic development, but more importantly, it will offer more patients, more options to fight cancer.
Auburn tabs USF’s Alex Golesh as its next coach, replacing Hugh Freeze on the Plains
The 41-year-old Golesh, who was born in Russia and moved to the United State at age 7, is signing a six-year contract that averages more than $7 million annually to replace Hugh Freeze. Freeze was fired in early November after failing to fix Auburn’s offensive issues in three seasons on the Plains.
Alabama Power seeks to delay rate hike for new gas plant amid outcry
The state’s largest utility has proposed delaying the rate increase from its purchase of a $622 million natural gas plant until 2028.
Former U.S. Sen. Doug Jones announces run for Alabama governor
Jones announced his campaign Monday afternoon, hours after filing campaign paperwork with the Secretary of State's Office. His gubernatorial bid could set up a rematch with U.S. Sen. Tommy Tuberville, the Republican who defeated Jones in 2020 and is now running for governor.
Scorching Saturdays: The rising heat threat inside football stadiums
Excessive heat and more frequent medical incidents in Southern college football stadiums could be a warning sign for universities across the country.
The Gulf States Newsroom is hiring an Audio Editor
The Gulf States Newsroom is hiring an Audio Editor to join our award-winning team covering important regional stories across Mississippi, Alabama and Louisiana.
Judge orders new Alabama Senate map after ruling found racial gerrymandering
U.S. District Judge Anna Manasco, appointed by President Donald Trump during his first term, issued the ruling Monday putting a new court-selected map in place for the 2026 and 2030 elections.
